Metabolomics

Dataset Information

0

Targeted Metabolomics Study: The Association Between Ovarian Function and Amino Acid Level Changes in Breast Cancer Patients Before and After Chemotherapy.


ABSTRACT:

Cyclophosphamide (CTX) is a primary medicine for curing breast cancer which often caused premature ovarian insufficiency (POI). Our recent publication reveals that CTX induced POI by promoting the expression of SLC1A4, a transporter of serine efflux, in ovarian granulosa cells (GCs). Here, we report that there is a closed connection between the reduction of serum serine and ovarian hypofunction in the breast cancer patients treated with CTX or women of childbearing age who are suffered from the staying-up-late. Additionally, we observe that dietary serine supplementation protects mice from CTX-induced POI without altering its anti-breast cancer. Furthermore, we demonstrate that the elevated serine promoted S1P synthesis, and in turn, inhibit the nuclear translocation of Nrf2 and consequent HO-1 expression, to suppress ferroptosis in GCs. Our study reveal that the chemotherapy-induced or idiopathic POI shared the same mechanisms, indicating that serine is a critical factor for maintaining ovarian function.

INSTRUMENT(S): Diode array detection MS - alternating - reverse-phase

PROVIDER: MTBLS13561 | MetaboLights | 2025-12-23

REPOSITORIES: MetaboLights

Dataset's files

Source:

Similar Datasets

2025-12-23 | GSE314714 | GEO
2023-10-30 | GSE243720 | GEO
2022-04-25 | GSE201223 | GEO
2019-04-17 | GSE129919 | GEO
2019-11-17 | GSE139665 | GEO
2019-11-17 | GSE139664 | GEO
2019-11-17 | GSE139663 | GEO
2022-08-22 | GSE211679 | GEO
2023-01-01 | GSE208179 | GEO
2025-06-16 | GSE294074 | GEO